𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance

✍ Scribed by Yan-Ping Hu; Sophie Jarillon; Catherine Dubernet; Patrick Couvreur; J. Robert


Publisher
Springer
Year
1996
Tongue
English
Weight
410 KB
Volume
37
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Reversal of drug resistance by erythromy
✍ Eva Hofsli; Jon Nissen-meyer πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 659 KB

Development of resistance to one type of lipophilic chemotherapeutic drug often leads to resistance to other, structurally unrelated, lipophilic drugs. This suggests that non-toxic lipophilic agents may interfere with and reverse drug resistance by saturating the pathway through which multidrugresis

The role of surfactants in the reversal
✍ Katrijn Bogman; FranΓ§oise Erne-Brand; Jochem Alsenz; JΓΌrgen Drewe πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 1 views

A variety of seven nonionic, one amphoteric and, one anionic surfactant that are applied or investigated as surfactants in drug formulation, were analyzed for their capacity to modulate carrier-mediated transport by efflux pumps. Two cell lines, murine monocytic leukemia cells overexpressing P-glyco

Anticancer multidrug resistance mediated
✍ AhcΓ¨ne Boumendjel; HΓ©lΓ¨ne Baubichon-Cortay; Doriane Trompier; Thomas Perrotton; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

## Abstract Multidrug resistance protein 1 (MRP1) belongs to the ATP‐binding cassette (ABC) transporter family. It is able to transport a broad range of anticancer drugs through cellular membranes, thus limiting their antiproliferative action. Since its discovery in 1992, MRP1 has been the most stu